메뉴 건너뛰기




Volumn 221, Issue 1, 2012, Pages 84-90

A phosphodiesterase 3 inhibitor, K-134, improves hindlimb skeletal muscle circulation in rat models of peripheral arterial disease

Author keywords

Blood flow; Ischemia; PDE3 inhibitor; Peripheral arterial disease; Peripheral vasculature; Platelet

Indexed keywords

ANTITHROMBOCYTIC AGENT; K 134; PHOSPHODIESTERASE III INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

EID: 84857034598     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.12.044     Document Type: Article
Times cited : (12)

References (24)
  • 1
    • 33845241195 scopus 로고    scopus 로고
    • The Trans-Atlantic Inter-Society Consensus (TASC II): document on management of peripheral arterial disease
    • Norgren L., Hiatt W.R., Dormandy J.A., et al. The Trans-Atlantic Inter-Society Consensus (TASC II): document on management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007, 33(Suppl 1):S1-S75.
    • (2007) Eur J Vasc Endovasc Surg , vol.33 , Issue.SUPPL 1
    • Norgren, L.1    Hiatt, W.R.2    Dormandy, J.A.3
  • 2
    • 33745602004 scopus 로고    scopus 로고
    • Intermittent claudication: an overview
    • Meru A.V., Mittra S., Thyagarajan B., et al. Intermittent claudication: an overview. Atherosclerosis 2006, 187:221-237.
    • (2006) Atherosclerosis , vol.187 , pp. 221-237
    • Meru, A.V.1    Mittra, S.2    Thyagarajan, B.3
  • 3
    • 70450189795 scopus 로고    scopus 로고
    • Inflammation in atherosclerosis: from pathophysiology to practice
    • Libby P., Ridker P.M., Hansson G.K., et al. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 2129-2138
    • Libby, P.1    Ridker, P.M.2    Hansson, G.K.3
  • 4
    • 42149099498 scopus 로고    scopus 로고
    • The molecular mechanisms of the thrombotic complications of atherosclerosis
    • Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 2008, 263:517-527.
    • (2008) J Intern Med , vol.263 , pp. 517-527
    • Libby, P.1
  • 5
    • 33748686575 scopus 로고    scopus 로고
    • Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use
    • Bender A.T., Beavo J.A. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006, 58:488-520.
    • (2006) Pharmacol Rev , vol.58 , pp. 488-520
    • Bender, A.T.1    Beavo, J.A.2
  • 6
    • 79952525002 scopus 로고    scopus 로고
    • Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation
    • Yoshida H., Okamura Y., Watanabe N., et al. Shear-dependent suppression of platelet thrombus formation by phosphodiesterase 3 inhibition requires low levels of concomitant Gs-coupled receptor stimulation. Thromb Haemost 2011, 105:487-495.
    • (2011) Thromb Haemost , vol.105 , pp. 487-495
    • Yoshida, H.1    Okamura, Y.2    Watanabe, N.3
  • 7
    • 0023944556 scopus 로고
    • Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle
    • Tanaka T., Ishikawa T., Hagiwara M., et al. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology 1988, 36:313-320.
    • (1988) Pharmacology , vol.36 , pp. 313-320
    • Tanaka, T.1    Ishikawa, T.2    Hagiwara, M.3
  • 8
    • 34548558967 scopus 로고    scopus 로고
    • NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model
    • Ishiwata N., Noguchi K., Kawanishi M., et al. NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase inhibitor, improves reduced walking distance and lowered hindlimb plantar surface temperature in a rat experimental intermittent claudication model. Life Sci 2007, 81:970-978.
    • (2007) Life Sci , vol.81 , pp. 970-978
    • Ishiwata, N.1    Noguchi, K.2    Kawanishi, M.3
  • 9
    • 0036839547 scopus 로고    scopus 로고
    • Collateral arteries grow from preexisting anastomoses in the rat hindlimb
    • Herzog S., Sager H., Khmelevski E., et al. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. Am J Physiol Heart Circ Physiol 2002, 283:H2012-H2020.
    • (2002) Am J Physiol Heart Circ Physiol , vol.283
    • Herzog, S.1    Sager, H.2    Khmelevski, E.3
  • 10
    • 0025940175 scopus 로고
    • Implications of thrombosis and vasospasm in peripheral vascular disease
    • Hollenberg N.K. Implications of thrombosis and vasospasm in peripheral vascular disease. J Cardiovasc Pharmacol 1991, 17(Suppl 5):S21-S28.
    • (1991) J Cardiovasc Pharmacol , vol.17 , Issue.SUPPL 5
    • Hollenberg, N.K.1
  • 11
    • 0021876264 scopus 로고
    • The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man
    • Akiyama H., Kudo S., Shimizu T. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittelforschung 1985, 35:1133-1140.
    • (1985) Arzneimittelforschung , vol.35 , pp. 1133-1140
    • Akiyama, H.1    Kudo, S.2    Shimizu, T.3
  • 12
    • 0035370855 scopus 로고    scopus 로고
    • Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia
    • Brevetti L.S., Paek R., Brady S.E., et al. Exercise-induced hyperemia unmasks regional blood flow deficit in experimental hindlimb ischemia. J Surg Res 2001, 98:21-26.
    • (2001) J Surg Res , vol.98 , pp. 21-26
    • Brevetti, L.S.1    Paek, R.2    Brady, S.E.3
  • 13
    • 0018903907 scopus 로고
    • Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats
    • Ashida S., Ishihara M., Ogawa H., et al. Protective effect of ticlopidine on experimentally induced peripheral arterial occlusive disease in rats. Thromb Res 1980, 18:55-67.
    • (1980) Thromb Res , vol.18 , pp. 55-67
    • Ashida, S.1    Ishihara, M.2    Ogawa, H.3
  • 14
    • 33645818728 scopus 로고    scopus 로고
    • Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats
    • Uemura T., Takamatsu H., Kawasaki T., et al. Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats. Eur J Pharmacol 2006, 536:154-161.
    • (2006) Eur J Pharmacol , vol.536 , pp. 154-161
    • Uemura, T.1    Takamatsu, H.2    Kawasaki, T.3
  • 15
    • 0029128480 scopus 로고
    • Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein
    • Abiru T., Endo K., Machida H. Differential vasodilatory action of 2-octynyladenosine (YT-146), an adenosine A2 receptor agonist, in the isolated rat femoral artery and vein. Eur J Pharmacol 1995, 281:9-15.
    • (1995) Eur J Pharmacol , vol.281 , pp. 9-15
    • Abiru, T.1    Endo, K.2    Machida, H.3
  • 16
    • 40149099168 scopus 로고    scopus 로고
    • Endothelial alpha1-adrenoceptors regulate neo-angiogenesis
    • Ciccarelli M., Santulli G., Campanile A., et al. Endothelial alpha1-adrenoceptors regulate neo-angiogenesis. Br J Pharmacol 2008, 153:936-946.
    • (2008) Br J Pharmacol , vol.153 , pp. 936-946
    • Ciccarelli, M.1    Santulli, G.2    Campanile, A.3
  • 17
    • 33644693118 scopus 로고    scopus 로고
    • Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system
    • Iaccarino G., Ciccarelli M., Sorriento D., et al. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 2005, 97:1182-1189.
    • (2005) Circ Res , vol.97 , pp. 1182-1189
    • Iaccarino, G.1    Ciccarelli, M.2    Sorriento, D.3
  • 18
    • 85047693822 scopus 로고    scopus 로고
    • Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles
    • Lee E.W., Michalkiewicz M., Kitlinska J., et al. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 2003, 111:1853-1862.
    • (2003) J Clin Invest , vol.111 , pp. 1853-1862
    • Lee, E.W.1    Michalkiewicz, M.2    Kitlinska, J.3
  • 19
    • 0028198615 scopus 로고
    • Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases
    • Sette C., Vicini E., Conti M. Modulation of cellular responses by hormones: role of cAMP specific, rolipram-sensitive phosphodiesterases. Mol Cell Endocrinol 1994, 100:75-79.
    • (1994) Mol Cell Endocrinol , vol.100 , pp. 75-79
    • Sette, C.1    Vicini, E.2    Conti, M.3
  • 20
    • 78049244831 scopus 로고    scopus 로고
    • Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo
    • Nakaya K., Ayaori M., Uto-Kondo H., et al. Cilostazol enhances macrophage reverse cholesterol transport in vitro and in vivo. Atherosclerosis 2010, 213:135-141.
    • (2010) Atherosclerosis , vol.213 , pp. 135-141
    • Nakaya, K.1    Ayaori, M.2    Uto-Kondo, H.3
  • 21
    • 67349112126 scopus 로고    scopus 로고
    • Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages
    • Okutsu R., Yoshikawa T., Nagasawa M., et al. Cilostazol inhibits modified low-density lipoprotein uptake and foam cell formation in mouse peritoneal macrophages. Atherosclerosis 2009, 204:405-411.
    • (2009) Atherosclerosis , vol.204 , pp. 405-411
    • Okutsu, R.1    Yoshikawa, T.2    Nagasawa, M.3
  • 22
    • 56649095559 scopus 로고    scopus 로고
    • Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription
    • Park S.Y., Lee J.H., Kim K.Y., et al. Cilostazol increases 3T3-L1 preadipocyte differentiation with improved glucose uptake associated with activation of peroxisome proliferator-activated receptor-gamma transcription. Atherosclerosis 2008, 201:258-265.
    • (2008) Atherosclerosis , vol.201 , pp. 258-265
    • Park, S.Y.1    Lee, J.H.2    Kim, K.Y.3
  • 23
    • 33750369864 scopus 로고    scopus 로고
    • Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism
    • Hashimoto A., Miyakoda G., Hirose Y., et al. Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 2006, 189:350-357.
    • (2006) Atherosclerosis , vol.189 , pp. 350-357
    • Hashimoto, A.1    Miyakoda, G.2    Hirose, Y.3
  • 24
    • 0033503548 scopus 로고    scopus 로고
    • Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease
    • Bramer S.L., Forbes W.P., Mallikaarjun S. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease. Clin Pharmacokinet 1999, 37(Suppl 2):1-11.
    • (1999) Clin Pharmacokinet , vol.37 , Issue.SUPPL 2 , pp. 1-11
    • Bramer, S.L.1    Forbes, W.P.2    Mallikaarjun, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.